Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
荔桔爽含片治疗急性咽炎(外感风热证)有效性和安全性的随机、双盲、安慰剂平行对照、剂量探索、多中心研究
[Translation] A randomized, double-blind, placebo-controlled, dose-finding, multicenter study on the efficacy and safety of Lijushuang lozenges in the treatment of acute pharyngitis (exogenous wind-heat syndrome)
试验主要目的为评价不同剂量的荔桔爽含片治疗急性咽炎(外感风热证)的安全性和有效性,初步评价剂量和效应的关系,为Ⅱb期临床试验方案的制定提供科学依据。
[Translation] The main purpose of the trial is to evaluate the safety and efficacy of different doses of Lijushuang lozenges in the treatment of acute pharyngitis (exogenous wind-heat syndrome), to preliminarily evaluate the relationship between dose and effect, and to provide a scientific basis for the formulation of a Phase IIb clinical trial plan.
评价热感糖浆治疗普通感冒(风热证)有效性和安全性的多中心、随机、双盲、阳性药及安慰剂平行对照IIb期临床试验
[Translation] A multicenter, randomized, double-blind, active-drug and placebo-controlled phase IIb clinical trial to evaluate the efficacy and safety of Regan Tangsyuo in the treatment of common cold (wind-heat syndrome)
在II期临床试验基础上,进一步探索热感糖浆治疗普通感冒(风热证)的有效性和安全性,为本品的后续试验提供数据支持。
[Translation] Based on the Phase II clinical trial, we will further explore the effectiveness and safety of Thermosylated Syrup in treating the common cold (wind-heat syndrome) and provide data support for subsequent trials of this product.
热感糖浆与安慰剂对照治疗感冒(风热证)随机、双盲、多中心临床试验
[Translation] A randomized, double-blind, multicenter clinical trial of heat syrup versus placebo in the treatment of cold (wind-heat syndrome)
[Translation] Preliminary evaluation of the effectiveness and safety of heat syrup in treating wind-heat cold
100 Clinical Results associated with Jiangxi Materia Medica Technology Co., Ltd.
0 Patents (Medical) associated with Jiangxi Materia Medica Technology Co., Ltd.
100 Deals associated with Jiangxi Materia Medica Technology Co., Ltd.
100 Translational Medicine associated with Jiangxi Materia Medica Technology Co., Ltd.